Literature DB >> 21553845

Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation.

Connie M Weaver1, Berdine R Martin, Cindy H Nakatsu, Arthur P Armstrong, Andrea Clavijo, Linda D McCabe, George P McCabe, Sinead Duignan, Margriet H C Schoterman, Ellen G H M van den Heuvel.   

Abstract

Galactooligosaccharides (GOS), prebiotic nondigestible oligosaccharides derived from lactose, have the potential for improving mineral balance and bone properties. This study examined the dose-response effect of GOS supplementation on calcium and magnesium absorption, mineral retention, bone properties, and gut microbiota in growing rats. Seventy-five 4-week-old male Sprague-Dawley rats were randomized into one of five treatment groups (n = 15/group) and fed a diet containing 0, 2, 4, 6, or 8% GOS by weight for 8 weeks. Dietary GOS significantly decreased cecal pH and increased cecal wall weight and content weight in a dose-dependent manner (p < 0.0001). Fingerprint patterns of the 16S rRNA gene PCR-DGGE from fecal DNA indicated the variance of bacterial community structure, which was primarily explained by GOS treatments (p = 0.0001). Quantitative PCR of the samples revealed an increase in the relative proportion of bifidobacteria with GOS (p = 0.0001). Net calcium absorption was increased in a dose-response manner (p < 0.01) with GOS supplementation. Dietary GOS also increased (p < 0.02) net magnesium absorption, femur ⁴⁵Ca uptake, calcium and magnesium retention, and femur and tibia breaking strength. Distal femur total and trabecular volumetric bone mineral density (vBMD) and area and proximal tibia vBMD increased (p < 0.02) with GOS supplementation. Trabecular-rich bones, that is, those that rapidly turn over, were most benefited. Regression modeling showed that GOS benefited calcium and magnesium utilization and vBMD through decreased cecal pH, increased cecal wall and content weight, and increased proportion of bifidobacteria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553845     DOI: 10.1021/jf2009777

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  40 in total

Review 1.  [Gut microbiota and osteoporosis].

Authors:  Yong-Quan Huang; Tao Jiang; Hai-Tao Su; Yi-Wen Luo; Qiu-Ke Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Anti-inflammatory effects of newly synthesized α-galacto-oligosaccharides on dextran sulfate sodium-induced colitis in C57BL/6J mice.

Authors:  Zhuqing Dai; Simin Feng; Anna Liu; Hong Wang; Xiaoxiong Zeng; Chung S Yang
Journal:  Food Res Int       Date:  2018-04-24       Impact factor: 6.475

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 4.  Osteoimmunology: from mice to humans.

Authors:  Patrizia D'Amelio; Francesca Sassi
Journal:  Bonekey Rep       Date:  2016-05-18

5.  Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model.

Authors:  Robert A Britton; Regina Irwin; Darin Quach; Laura Schaefer; Jing Zhang; Taehyung Lee; Narayanan Parameswaran; Laura R McCabe
Journal:  J Cell Physiol       Date:  2014-11       Impact factor: 6.384

Review 6.  The gut-bone axis: how bacterial metabolites bridge the distance.

Authors:  Mario M Zaiss; Rheinallt M Jones; Georg Schett; Roberto Pacifici
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

Review 7.  Diet, gut microbiome, and bone health.

Authors:  Connie M Weaver
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

Review 8.  Prebiotic and Probiotic Regulation of Bone Health: Role of the Intestine and its Microbiome.

Authors:  Laura McCabe; Robert A Britton; Narayanan Parameswaran
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

9.  Effect of a combination GOS/FOS® prebiotic mixture and interaction with calcium intake on mineral absorption and bone parameters in growing rats.

Authors:  Gabriel Bryk; Magalí Zeni Coronel; Gretel Pellegrini; Patricia Mandalunis; María Ester Rio; María Luz Pita Martín de Portela; Susana Noemí Zeni
Journal:  Eur J Nutr       Date:  2014-09-21       Impact factor: 5.614

10.  Montmorency tart cherry protects against age-related bone loss in female C57BL/6 mice and demonstrates some anabolic effects.

Authors:  Brenda J Smith; Erica K Crockett; Pitipa Chongwatpol; Jennifer L Graef; Stephen L Clarke; Elizabeth Rendina-Ruedy; Edralin A Lucas
Journal:  Eur J Nutr       Date:  2018-10-30       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.